VisMederi Holding

Improving human health

Vismederi Holding

Vismederi Holding is the company that holds a qualified share of the companies that are part of the VisMederi Group. The Group of Vismederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Accurange Srl.

Vismederi Holding
0Mln €

Revenues

0

Employees 

0Paesi

Global Partnerships

Vismederi Holding: latest news

All the news of the group

May 22 2024

VIII International Conference and Exhibition IVW 2024 in Siena

The eighth edition of the "Influenza Vaccines for the World—IVW 2024" conference and exhibition is currently taking place in Siena (May 21–23,...
May 10 2024

VisMederi and the International Vaccine Institute have formed a new partnership to accelerate vaccine development in developing countries.

VisMederi and the International Vaccine Institute have formed a new partnership to accelerate vaccine development in developing countries....
Apr 29 2024

VisMederi Diagnostics opens a new collection point in Siena

Our new collection point will soon open at the Fisiomedical Center, located at Via Cesare Battisti 24, in Siena. We are already present at the...
Apr 16 2024

Simone Paletti, Chief Financial Officer, speaker at the key finance forum in Milan organized by “Comunicazione Italiana”

Simone Paletti, Chief Financial Officer at VisMederi Group, recently attended a key finance forum in Milan organized by "Comunicazione Italiana"....
Apr 16 2024

VisMederi Group at the World Vaccine Congress in Washington, D.C.

VisMederi Group attended the World Vaccine Congress in Washington, D.C., acknowledged as the most significant and longstanding event dedicated to...
Apr 16 2024

VisMederi has achieved a distinguished place in the prestigious FT 1000 ranking by the Financial Times

VisMederi has achieved a distinguished place in the prestigious FT 1000 ranking by the Financial Times, securing the 346th position among Europe's...
Apr 16 2024

VisMederi at the University of Siena’s prestigious event “USiena Game”

Elisa Mennitto, Chief Facilities and Lab Officer, represented VisMederi at the University of Siena's prestigious event "USiena Game". Addressing...
Jan 25 2024

Our manuscript “#CEPI Centralized Laboratory Network: a qualification analysis” has been published in The Lancet Microbe Online

Our manuscript "#CEPI Centralized Laboratory Network: a qualification analysis" has been published in The Lancet Microbe Online. This publication...
Jan 18 2024

New Research Highlights the Importance of Vaccinations in Leukemia Patients

VisMederi is excited to share a significant breakthrough in medical research conducted in collaboration with Landspítali University of Reykjavík,...
Nov 23 2023

Making Strides in Global Health: VisMederi at the World Bio Summit 2023!

VisMederi, represented by the Founder and CSO Prof. Emanuele Montomoli, played a pivotal role at the esteemed World Bio Summit 2023 in Seoul. This...

Where we

are

 

 

 

 

 

 

The

founder

Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

Prestigious visit at VisMederi! Yesterday, we had the honor of welcoming Antonio Mazzeo, President of the Regional Council, to VisMederi.

Alongside our CDO Alessandro Manenti and CFLO Elisa Mennitto, they discussed the exciting future development opportunities for VisMederi, both regionally and internationally.

#vismederi #Leadership #Innovation #globalvision

*************
Antonio Mazzeo, Presidente del Consiglio Regionale, a VisMederi. Insieme al CDO Alessandro Manenti e al CFLO Elisa Mennitto, hanno parlato delle emozionanti opportunità di sviluppo futuro per VisMederi, sia a livello regionale che internazionale.

#innovazione #visioneglobale #vismederigroup

Antonio Mazzeo
... See MoreSee Less

Prestigious visit at VisMederi!  Yesterday, we had the honor of welcoming Antonio Mazzeo, President of the Regional Council, to VisMederi. 

Alongside our CDO Alessandro Manenti and CFLO Elisa Mennitto, they discussed the exciting future development opportunities for VisMederi, both regionally and internationally.

#VisMederi #Leadership #Innovation #GlobalVision

*************
Antonio Mazzeo, Presidente del Consiglio Regionale, a VisMederi. Insieme al CDO Alessandro Manenti e al CFLO Elisa Mennitto, hanno parlato delle emozionanti opportunità di sviluppo futuro per VisMederi, sia a livello regionale che internazionale. 

#Innovazione #VisioneGlobale  #VisMederigroup

Antonio MazzeoImage attachment

We are excited to announce our new partnership with the International Vaccine Institute (IVI), an international nonprofit institution committed to vaccine research and development for developing countries.

This agreement reinforces our mission to improve global public health through innovation in vaccines.

Together, we will address global health challenges that threaten the most vulnerable populations by sharing expertise and resources to accelerate the introduction of new vaccines.

Read the the news here: www.vismederiholding.com/vismederi-and-the-international-vaccine-institute-have-formed-a-new-part...

#VisMederi #IVI #Vaccines #GlobalHealth #Research #Development #Innovation #Partnerships International Vaccine Institute

°°°°°°°°°°°°

Siamo entusiasti di annunciare la nostra nuova partnership con l’International Vaccine Institute (IVI), un’istituzione internazionale non profit impegnata nella ricerca e nello sviluppo di vaccini per i Paesi in via di sviluppo.

Questo accordo rafforza la nostra missione di migliorare la salute pubblica globale attraverso l’innovazione nel settore dei vaccini.

Insieme, affronteremo le sfide sanitarie globali che minacciano le popolazioni più vulnerabili, condividendo competenze e risorse per accelerare l’introduzione di nuovi vaccini.

Leggi qui la notizia: www.vismederiholding.com/it/vismederi-and-the-international-vaccine-institute-have-formed-a-new-p...

#VisMederi #IVI #Vaccini #SaluteGlobale #Ricerca #Sviluppo #Innovazione #Partnership #vismederigroup
... See MoreSee Less

We are excited to announce our new partnership with the International Vaccine Institute (IVI), an international nonprofit institution committed to vaccine research and development for developing countries. 

This agreement reinforces our mission to improve global public health through innovation in vaccines. 

Together, we will address global health challenges that threaten the most vulnerable populations by sharing expertise and resources to accelerate the introduction of new vaccines. 

Read the the news here: https://www.vismederiholding.com/vismederi-and-the-international-vaccine-institute-have-formed-a-new-partnership-to-accelerate-vaccine-development-in-developing-countries/

#VisMederi #IVI #Vaccines #GlobalHealth #Research #Development #Innovation #Partnerships  International Vaccine Institute 

°°°°°°°°°°°°

Siamo entusiasti di annunciare la nostra nuova partnership con l’International Vaccine Institute (IVI), un’istituzione internazionale non profit impegnata nella ricerca e nello sviluppo di vaccini per i Paesi in via di sviluppo. 

Questo accordo rafforza la nostra missione di migliorare la salute pubblica globale attraverso l’innovazione nel settore dei vaccini. 

Insieme, affronteremo le sfide sanitarie globali che minacciano le popolazioni più vulnerabili, condividendo competenze e risorse per accelerare l’introduzione di nuovi vaccini. 

Leggi qui la notizia: https://www.vismederiholding.com/it/vismederi-and-the-international-vaccine-institute-have-formed-a-new-partnership-to-accelerate-vaccine-development-in-developing-countries/

#VisMederi #IVI #Vaccini #SaluteGlobale #Ricerca #Sviluppo #Innovazione #Partnership #vismederigroupImage attachmentImage attachment+1Image attachment

Great news from Vismederi Diagnostics🔍 Novità Importanti da VisMederi Diagnostics!

Aprirà a breve il nostro nuovo punto prelievi nei locali del centro Fisiomedical in via Cesare Battisti 24, a Siena.

Siamo già presenti al centro Riabilitiamo in strada della Tressa alla Coroncina e con questa nuova apertura rafforziamo la nostra offerta di servizi di alta qualità nel settore della diagnostica e la capacità di servire efficacemente la comunità.

Per maggiori informazioni sui dettagli di questa importante espansione, vi invitiamo a leggere l'articolo su Siena News
: sienanews.it/toscana/siena/vismederi-punta-sulla-diagnostica-in-citta-un-nuovo-punto-prelievi-e-i...

Gli orari di apertura dei punti prelievi

Al centro Riabilitiamo, in strada della Tressa 9 alla Coroncina: lunedì, mercoledì, giovedì e venerdì dalle 7 alle 11; il martedì dalle 7 alle 8.30. Al centro Fisiomedical in via Battisti 24 (quando sarà aperto il punto prelievi): dal lunedì al venerdì dalle 7 alle 10. Tel: +39 348 4838437; e-mail info@vismederidiagnostics.com; sito: www.vismederidiagnostics.com

#VisMederiDiagnostics #Diagnostica #Innovazione #Siena
... See MoreSee Less

Great news from Vismederi Diagnostics
1 month ago

CeRDI Scientific Advisory Board at Butantan Institute. Fruitful discussion and urgent actions for vaccination strategies in Latin America. (cerdi.butantan.gov.br/)
"INSTITUTO BUTANTAN a serviço da vida" muito obrigado !
#VaccineSaveLives #vaccines
... See MoreSee Less

CeRDI Scientific Advisory Board at Butantan Institute. Fruitful discussion and urgent actions for vaccination strategies in Latin America. (https://cerdi.butantan.gov.br/) 
INSTITUTO BUTANTAN a serviço da vida muito obrigado !
#VaccineSaveLives #vaccinesImage attachmentImage attachment+2Image attachment

1 CommentComment on Facebook

👏🏼

Load more